Mortazavi S M Javad, Moharrami Alireza, Shafiei Hossein, Ebrahimzadeh Mohammad H, Karimi Mehdi
Joint Reconstruction Research Center (JRRC), Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran.
Orthopedic Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Arch Bone Jt Surg. 2019 Nov;7(6):561-565.
Avascular necrosis of the femoral head (AVNFH) is a leading cause of end-stage joint disease in the young population that can lead to total hip replacement in early life. There are various risk factors, including trauma, corticosteroids, thrombosis, hypertension, and alcohol. There is a growing number of patients with AVNFH and history of self-medication with herbal supplement used for weight gain in Iran. The present study aimed to demonstrate the prevalence rate of using unapproved weight gain supplements (UWGS) in patients with AVNFH. An observational and cross-sectional study was conducted to estimate the prevalence rate of using UWGSs in patients with osteonecrosis at Imam Khomeini Hospital, Tehran, Iran, from January 2012 to 2018. The data were analyzed in SPSS software (version 24) through descriptive statistics and tests of means. Out of 207 patients with AVNFH, 115 cases were male. In total, 44 patients (20.95%) had a history of using UWGSs, and there had no other risk factors of osteonecrosis of FH. In conclusion, UWGSs can be a risk factor for AVNFH, and it is necessary to develop educational programs to alert young population about the side effects of these supplements.
股骨头缺血性坏死(AVNFH)是导致年轻人群终末期关节疾病的主要原因,可致使早年进行全髋关节置换。存在多种风险因素,包括创伤、皮质类固醇、血栓形成、高血压和酒精。在伊朗,股骨头缺血性坏死患者以及有自行服用用于增重的草药补充剂病史的患者数量日益增多。本研究旨在表明股骨头缺血性坏死患者中使用未经批准的增重补充剂(UWGS)的患病率。2012年1月至2018年,在伊朗德黑兰伊玛目霍梅尼医院开展了一项观察性横断面研究,以估算骨坏死患者中使用UWGS的患病率。通过描述性统计和均值检验在SPSS软件(版本24)中对数据进行分析。在207例股骨头缺血性坏死患者中,115例为男性。共有44例患者(20.95%)有使用UWGS的病史,且无其他股骨头缺血性坏死的风险因素。总之,UWGS可能是股骨头缺血性坏死的一个风险因素,有必要开展教育项目,提醒年轻人群注意这些补充剂的副作用。